HPV is a group of more than 200 related viruses, which spreads mostly through anal, oral, and vaginal sex. The sexually transmitted HPV infections are categorized into two groups: low-grade, and high-grade HPVs. HPV is generally transmitted through vaginal intercourse, oral and anal sex, and also by intimate skin-to-skin contact. The condoms and dental dams can reduce the likelihood of HPV transmission. Some of the risk factors of this infectious disease are smoking, infectious HPV type, increasing age, immunodeficiency, unprotected sexual intercourse, and presence of other sexually transmitted infections (STIs).
Download the sample copy of pages at: https://www.pharmaproff.com/request-sample/1254
HSV on the other hand is a viral infection which affects the mouth, genitals, or anal area. The virus can spread from one person to another causing outbreaks of sores. HSVs can be categorized into two types: HSV-1 and HSV-2. HSV-1 is majorly transmitted by oral-to-oral contact via sores, saliva, and surfaces in or around the mouth. However, HSV-1 can also be transmitted to the genital area through oral-genital contact, which leads to genital herpes. HSV-2 is mainly transmitted through contact with genital surfaces, skin, sores or fluids of someone infected with the virus.
Get the detailed overview at: https://www.pharmaproff.com/report/hpv-and-hsv-infections
According to the research findings, the global incidence of HPV infections has increased substantially in the past decade. Amongst the 12MM, India is likely to have the highest number of incident cases of HPV infections. On the other hand, the incident cases are expected to be the lowest in Spain among the 12MM, with 8,906 people likely to be affected by this disease by 2028. Besides, women are slightly more prone to this disease, due to the increasing prevalence of HPV-associated cervical cancers. Further, due to the poor diagnosis of cervical and other cancers, majority of the cases cannot be diagnosed.
It has been observed that, the people aged 15 to 49 years are the most affected by the virus. According to the World Health Organization (WHO) in 2015, approximately 140.0 million people aged 15-49 years were infected with genital HSV-1 infection, primarily in America, Europe, and Western Pacific. However, less people are infected with HSV-1 in high-income countries, due to better hygiene and living conditions. In 2015, the WHO estimated that globally around 417 million people aged 15-49 years have HSV-2 infection, which causes genital herpes.
HPV and HSV Infections Epidemiology Analysis
- By Type
- By Sex
The report provides detailed overview of HPV and HSV infections, highlighting the causes, risk factors, classification, prognosis, pathophysiology, unmet medical needs, diagnosis, and treatment options for the diseases. The report also provides comprehensive insights into global trends of HSV and HPV infections in the 12MM. Moreover, the incidence of HSV and HPV infections for historical and forecasted periods has been analyzed in-depth and is further segmented into type-specific (for HSV) and sex- specific data (for both HSV and HPV infections).
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]